Crinetics Pharmaceuticals, Inc.

NasdaqGS:CRNX Stock Report

Market Cap: US$5.4b

Crinetics Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:CRNX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 Mar 24SellUS$107,075Jeff KnightIndividual2,359US$45.39
20 Mar 24SellUS$31,195Dana PizzutiIndividual714US$43.69
28 Feb 24BuyUS$20,000,022Perceptive Advisors LLCCompany476,191US$42.00
15 Feb 24SellUS$0Perceptive Advisors LLCCompany1,274,647US$36.36

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of CRNX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,279,0201.42%
General Public2,132,2012.37%
Institutions86,624,38996.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 34.8%.


Top Shareholders

Top 25 shareholders own 72.16% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.98%
The Vanguard Group, Inc.
6,287,655US$377.3m39.3%0.01%
6.92%
BlackRock, Inc.
6,230,371US$373.9m14.6%0.01%
6.79%
Driehaus Capital Management LLC
6,112,173US$366.8m16.9%2.18%
6.39%
T. Rowe Price Group, Inc.
5,753,666US$345.3m-11.2%0.03%
5.13%
Wellington Management Group LLP
4,620,413US$277.3m55.5%0.04%
4.62%
EcoR1 Capital, LLC
4,155,375US$249.4m0%7.68%
4.55%
FMR LLC
4,096,288US$245.8m-8.22%0.01%
3.15%
State Street Global Advisors, Inc.
2,838,484US$170.3m0.91%0.01%
3.1%
Jennison Associates LLC
2,793,614US$167.6m0.48%0.1%
3.09%
Point72 Asset Management, L.P.
2,780,856US$166.9m-43.8%0.38%
2.79%
Paradigm Biocapital Advisors LP
2,513,302US$150.8m-19.6%4.57%
2.73%
Janus Henderson Group plc
2,455,661US$147.4m24.1%0.06%
1.86%
Geode Capital Management, LLC
1,678,387US$100.7m19.8%0.01%
1.64%
Perceptive Advisors LLC
1,476,203US$88.6m0%1.73%
1.5%
Cormorant Asset Management, LP
1,350,000US$81.0m17.4%3.44%
1.42%
OrbiMed Advisors LLC
1,280,800US$76.9m-7.52%0.99%
1.33%
First Light Asset Management, LLC
1,200,508US$72.0m-29%5.45%
1.18%
Artal Group S.A.
1,066,064US$64.0m-23.3%1.31%
1.14%
Medical Strategy GmbH, Asset Management Arm
1,022,572US$61.4m42.8%3.47%
1.13%
R. Struthers
1,021,353US$61.3m1.96%no data
1.11%
Novo Holdings A/S
1,000,000US$60.0m0%0.04%
0.99%
Lord, Abbett & Co. LLC
887,921US$53.3m-7.95%0.15%
0.96%
Franklin Resources, Inc.
861,226US$51.7m109%0.02%
0.84%
Morgan Stanley, Investment Banking and Brokerage Investments
752,629US$45.2m45%0.01%
0.82%
Eventide Asset Management, LLC
735,088US$44.1m-30.6%0.69%